title: An insult-inducible vector system activated by hypoxia and oxidative stress for neuronal gene therapy.
abstract: Gene therapy has demonstrated the protective potential of a variety of genes against stroke. However, conventional gene therapy vectors are limited due to the inability to temporally control their expression, which can sometimes lead to deleterious side effects. Thus, an inducible vector that can be temporally controlled and activated by the insult itself would be advantageous. Using hypoxia responsive elements (HRE) and antioxidant responsive elements (ARE), we have constructed an insult-inducible vector activated by hypoxia and reactive oxygen species (ROS). In COS7 cells, the inducible ARE-HRE-luciferase vectors are highly activated by oxygen deprivation, hydrogen peroxide treatment, and the ROS-induced transcription factor NF-E2-related factor 2 (Nrf2). Using a defective herpes virus, the neuroprotective potential of this inducible vector was tested by over-expressing the transcription factor Nrf2. In primary cortical cultures, expression of the inducible ARE-HRE-Nrf2 protects against oxygen glucose deprivation, similar to that afforded by the constitutively expressed Nrf2. This ARE+HRE vector system is advantageous in that it allows the expression of a transgene to be activated not only during hypoxia but also maintained after reperfusion, thus prolonging the transgene expression during an ischemic insult. This insult-inducible vector system will be a valuable gene therapy tool for activating therapeutic/protective genes in cerebrovascular diseases.
authors: Department of Biology, Stanford University, 371 Serra Mall, Stanford, CA 94305-5020, USA.
authors: Michelle Y
authors: MY
authors: Cheng
authors: I-Ping
authors: IP
authors: Lee
authors: Michael
authors: M
authors: Jin
authors: Guohua
authors: G
authors: Sun
authors: Heng
authors: H
authors: Zhao
authors: Gary K
authors: GK
authors: Steinberg
authors: Robert M
authors: RM
authors: Sapolsky
references: J Clin Invest. 2003 Jun;111(12):1843-51
references: 12813020
references: Gene Ther. 2006 May;13(10):857-68
references: 16467859
references: Neurobiol Dis. 2001 Aug;8(4):655-66
references: 11493030
references: Biochem Biophys Res Commun. 2005 Jan 14;326(2):371-7
references: 15582588
references: Ann Surg Oncol. 2005 Dec;12(12):1025-36
references: 16244806
references: J Neurosci Methods. 1995 Apr;57(2):205-15
references: 7609584
references: Adv Exp Med Biol. 2000;475:123-30
references: 10849654
references: J Appl Physiol (1985). 2000 Apr;88(4):1474-80
references: 10749844
references: Nature. 1999 Jun 24;399(6738 Suppl):A7-14
references: 10392575
references: FASEB J. 2006 Dec;20(14):2624-6
references: 17142801
references: Neuroscience. 2007 Jun 15;147(1):53-9
references: 17507167
references: Invest Ophthalmol Vis Sci. 1999 Jan;40(1):182-9
references: 9888442
references: Stroke. 2006 Oct;37(10):2601-6
references: 16946160
references: Gene Ther. 2008 Sep;15(18):1271-9
references: 18449215
references: Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5510-4
references: 7539918
references: Eur J Neurosci. 1999 Dec;11(12):4159-70
references: 10594641
references: J Neurochem. 2007 Apr;101(1):109-19
references: 17394461
references: Nat Rev Neurosci. 2004 Jun;5(6):437-48
references: 15152194
references: Annu Rev Neurosci. 1996;19:265-87
references: 8833444
references: J Biol Chem. 2005 Jun 17;280(24):22925-36
references: 15840590
references: Surg Neurol. 2006 Sep;66(3):232-45
references: 16935624
references: Neurology. 1999 Dec 10;53(9):1922-31
references: 10599759
references: J Neurosci Res. 2009 May 15;87(7):1659-69
references: 19125416
references: J Cell Sci. 2006 Aug 15;119(Pt 16):3467-80
references: 16899821
references: Curr Pharm Des. 2004;10(8):879-91
references: 15032691
references: Dev Biol Stand. 1994;82:79-87
references: 7958486
references: Neurol Res. 2001 Jul;23(5):543-52
references: 11474812
references: J Neurosci. 2005 Nov 2;25(44):10321-35
references: 16267240
references: Neurobiol Dis. 2002 Mar;9(2):187-204
references: 11895371
references: Circulation. 2000 Aug 22;102(8):898-901
references: 10952959
references: J Cereb Blood Flow Metab. 1998 Feb;18(2):196-205
references: 9469163
references: J Neurosci. 2003 Apr 15;23(8):3394-406
references: 12716947
references: Trends Neurosci. 2001 Dec;24(12):695-700
references: 11718873
references: Pediatr Res. 2001 May;49(5):614-7
references: 11328942
references: Nature. 2005 Dec 15;438(7070):954-9
references: 16355213
references: Am J Physiol. 1998 Oct;275(4):L818-26
references: 9755115
references: Gene Ther. 2001 Dec;8(23):1801-7
references: 11803400
references: Stroke. 1995 Sep;26(9):1670-4; discussion 1675
references: 7544927
references: Methods Enzymol. 2004;378:273-86
references: 15038975
references: Neurology. 2006 Jun 13;66(11):1742-4
references: 16769953
references: Trends Mol Med. 2004 Nov;10(11):549-57
references: 15519281
references: Neurosci Lett. 1999 May 21;267(1):21-4
references: 10400239
references: Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9270-5
references: 10908682
references: Nat Rev Neurosci. 2003 Jan;4(1):61-9
references: 12511862